Background: The number of patients with diabetes mellitus (DM) seeking treatment for degenerative spondylolisthesis is expected to increase. However, there is a paucity of studies examining the patient-reported outcomes (PROs) and subjective measures in patients with DM following minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF). The present study aimed to compare PROs, satisfaction, and radiological fusion between DM and non-DM patients following MIS-TLIF.
Methods: The authors identified 30 patients with DM who underwent primary, single-level MIS-TLIF for degenerative spondylolisthesis from a spine registry. Each patient was matched 1:1 with 30 controls without DM using propensity scores to adjust for age, sex, body mass index, American Society of Anesthesiologists class, and baseline PROs. Visual analog scale leg pain, back pain, Oswestry Disability Index (ODI), SF-36 physical component score and mental component scores were compared at 1, 3, 6, and 24 months. Patients also completed a satisfaction questionnaire during these visits. Radiographic fusion was analyzed according to Bridwell grades.
Results: There was no difference in PROs between non-DM and DM patients at 2 years. However, a higher proportion of non-DM patients attained minimal clinically important difference for ODI (90.0% vs 66.7% = 0.028) and SF-36 physical component score (90.0% vs 53.3% = 0.002) at 3 months and ODI (96.7% vs 80.0%) at 6 months. A similar proportion of patients in each group were satisfied and had expectations fulfilled. A higher proportion of non-DM patients attained a grade 1 or 2 fusion (93.3%), as compared with DM patients (80.0%), although this did not reach statistical significance ( = 0.129).
Conclusions: DM patients have poorer initial PROs, which reach comparable levels to those in non-DM patients in the longer-term. Fusion rates of DM patients were poorer compared with non-DM patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623677 | PMC |
| http://dx.doi.org/10.14444/8535 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Higher Incidence of Diabetes in Asymptomatic Healthy Fatty Liver Patients of Bangladesh: Prompt Intervention can Avert Complications.
Euroasian J Hepatogastroenterol
December 2024
Department of Hepatology, Sheikh Hasina Medical College Hospital, Tangail, Bangladesh.
Background: The strong association between type 2 diabetes mellitus (T2DM) and fatty liver is well known, and its nomenclature has even recently changed to metabolic dysfunction-associated steatotic liver disease (MASLD). Healthy MASLD patients are frequently overlooked and maltreated, especially in Bangladesh. In this present study, we tried to correlate T2DM burden in apparently healthy, incidentally diagnosed fatty liver patients on ultrasound.
View Article and Find Full Text PDFLower Serum IL-10 Linked to Oral Manifestations in Diabetes Patients.
Diabetes Metab Syndr Obes
January 2025
Oral Medicine Department, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia.
Background: Diabetes mellitus (DM) is a chronic disease that remains a global health problem with increasing prevalence, particularly in Indonesia. The presence of oral manifestations in patients with DM is influenced by changes in immune system function. Interleukin-10 (IL-10) is an inflammatory marker implicated in DM.
View Article and Find Full Text PDFAssociation of diabetes mellitus with long-term prognosis after ablation therapy for patients with hepatocellular carcinoma: A single-center cohort study.
J Cancer Res Ther
December 2024
Department of Ultrasonic Intervention, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
Background: This study investigated the clinical efficacy and prognostic factors of ablative treatment in hepatocellular carcinoma (HCC) patients with and without diabetes mellitus (DM).
Methods: Retrospective data were collected from HCC patients who underwent ablation between January 2016 and December 2019. The baseline clinicopathological characteristics and long-term outcomes, such as overall survival (OS) and recurrence-free survival (RFS), were compared between those with and without DM.
Hyperuricemia Is Associated With Higher Mortality in Non-diabetic Heart Failure Patients.
Cureus
December 2024
Department of Internal Medicine, Unidade Local de Saúde de São João, Porto, PRT.
Introduction: Hyperuricemia (HU) is associated with an increased risk of incident heart failure (HF) and adverse HF outcomes. Patients with diabetes mellitus (DM) have a greater prevalence of HU.
Aims: We evaluated the prognostic impact of HU in patients with HF according to the coexistence of DM.
Investigating Some Effective Factors on the Prediction of Continuous Positive Airway Pressure Failure Rate in COVID-19-Related Hypoxemia.
Iran J Nurs Midwifery Res
November 2024
Department of Operating Room, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran.
Article Synopsis
- The study aimed to identify factors influencing CPAP failure rates in patients with COVID-19-related hypoxemia, analyzing 200 ICU patients in southwestern Iran.
- Results showed a high CPAP failure rate (78.5%), particularly linked to higher HACOR scores, diabetes mellitus, older age, obesity, and elevated Blood Urea Nitrogen levels.
- The findings suggest that specific clinical factors such as HACOR scores and comorbidities significantly impact the effectiveness of CPAP therapy in these patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!